These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency. Goday A; Simmonds HA; Morris GS; Fairbanks LD Biochem Pharmacol; 1985 Oct; 34(19):3561-9. PubMed ID: 3876835 [TBL] [Abstract][Full Text] [Related]
8. Rejection of bone marrow transplant and resistance of alloantigen reactive cells to in vivo deoxyadenosine in adenosine deaminase deficiency. Cowan MJ; Shannon KM; Wara DW; Ammann AJ Clin Immunol Immunopathol; 1988 Nov; 49(2):242-50. PubMed ID: 2971490 [TBL] [Abstract][Full Text] [Related]
9. Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency. Cohen A; Hirschhorn R; Horowitz SD; Rubinstein A; Polmar SH; Hong R; Martin DW Proc Natl Acad Sci U S A; 1978 Jan; 75(1):472-6. PubMed ID: 272665 [TBL] [Abstract][Full Text] [Related]
10. Erythrocyte adenosine deaminase deficiency without immunodeficiency. Evidence for an unstable mutant enzyme. Hirschhorn R; Roegner V; Jenkins T; Seaman C; Piomelli S; Borkowsky W J Clin Invest; 1979 Oct; 64(4):1130-9. PubMed ID: 479373 [TBL] [Abstract][Full Text] [Related]
11. Adenosine deaminase deficiency: disappearance of adenine deoxynucleotides from a patient's erythrocytes after successful marrow transplantation. Chen SH; Ochs HD; Scott CR; Giblett ER; Tingle AJ J Clin Invest; 1978 Dec; 62(6):1386-9. PubMed ID: 372236 [TBL] [Abstract][Full Text] [Related]
12. Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitro: relevance to the therapeutic use of inhibitors of adenosine deaminase. Lee N; Russell N; Ganeshaguru K; Jackson BF; Piga A; Prentice HG; Foa R; Hoffbrand AV Br J Haematol; 1984 Jan; 56(1):107-19. PubMed ID: 6231047 [TBL] [Abstract][Full Text] [Related]
13. Adenosine and deoxyadenosine metabolism in the erythrocytes of a patient with adenosine deaminase deficiency. Sahota A; Simmonds HA; Potter CF; Watson JG; Hugh-Jones K; Perrett D Adv Exp Med Biol; 1980; 122A():397-401. PubMed ID: 6999851 [No Abstract] [Full Text] [Related]
14. dATP accumulation and ATP depletion in platelets in adenosine deaminase deficiency: significance for the immune response? Simmonds HA; Goday A; Morris GS; Fairbanks LD; Levinsky RJ Biosci Rep; 1984 Oct; 4(10):809-18. PubMed ID: 6335053 [TBL] [Abstract][Full Text] [Related]
15. ATP depletion as a consequence of adenosine deaminase inhibition in man. Siaw MF; Mitchell BS; Koller CA; Coleman MS; Hutton JJ Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6157-61. PubMed ID: 6969403 [TBL] [Abstract][Full Text] [Related]
16. Adenosine deaminase deficiency with normal immune function. An acidic enzyme mutation. Daddona PE; Mitchell BS; Meuwissen HJ; Davidson BL; Wilson JM; Koller CA J Clin Invest; 1983 Aug; 72(2):483-92. PubMed ID: 6603477 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes. Bontemps F; Van den Berghe G Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493 [TBL] [Abstract][Full Text] [Related]
18. Nucleotide levels and metabolism of adenosine and deoxyadenosine in intact erythrocytes deficient in adenosine deaminase. Webster DR; Simmonds HA; Perrett D; Levinsky RJ Adv Exp Med Biol; 1984; 165 Pt A():363-6. PubMed ID: 6609529 [No Abstract] [Full Text] [Related]
19. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia. Yu AL; Bakay B; Kung FH; Nyhan WL Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800 [TBL] [Abstract][Full Text] [Related]